Housekeeping genes in prostate tumorigenesis

International Journal of Cancer

Volumn 125, Issue 11, 2009, Pages 2603-2608

  Byun, Jinyoung ^a   Logothetis, Christopher J ^a   Gorlov, Ivan P ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Gene expression; HK genes; Meta analysis; Prostate cancer

Indexed keywords

BIOLOGICAL MARKER; HEAT SHOCK PROTEIN; RIBOSOME PROTEIN;

ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CARCINOGENESIS; CELL PROLIFERATION; CELL STRESS; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GLEASON SCORE; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION; ESSENTIAL GENE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; META ANALYSIS; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ESSENTIAL; GENOME, HUMAN; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 70350738497     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24680     Document Type: Article

References (53)

1. De Ferrari L, Aitken S. Mining housekeeping genes with a Naive Bayes classifier. BMC Genomics 2006;7:277. (Pubitemid 44734369)
2. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A. Evidence based selection of housekeeping genes. PLoS ONE. 2007;2:e898.
3. Haverty PM, Weng Z, Best NL, Auerbach KR, Hsiao LL, Jensen RV, Gullans SR. HugeIndex: a database with visualization tools for high-density oligonucleotide array data from normal human tissues. Nucleic Acids Res 2002;30:214-217 (Pubitemid 34679546)
4. Eisenberg E, Levanon EY. Human housekeeping genes are compact. Trends Genet 2003;19:362-365 (Pubitemid 36794535)
5. Hsiao LL, Dangond F, Yoshida T, Hong R, Jensen RV, Misra J, Dillon W, Lee KF, Clark KE, Haverty P, Weng Z, Mutter GL, et al. A compendium of gene expression in normal human tissues. Physiol Genomics 2001;7:97-104.
6. Suzuki H, Morris JS, Li Y, Doll MA, Hein DW, Liu J, Jiao L, Hassan MM, Day RS, Bondy ML, Abbruzzese JL, Li D. Interaction of the cytochrome P4501A2. SULT1A1 and. NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis 2008; 29:1184-1191
7. Luby TM. Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine. Expert Rev Vaccines 2008;7:995-1003.
8. Taylor CA, Sun Z, Cliche DO, Ming H, Eshaque B, Jin S, Hopkins MT, Thai B, Thompson JE. Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling. Exp Cell Res 2007;313:437-449
9. Salehi Z, Mashayekhi F. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer. Clin Biochem 2006;39:404-409
10. Lai MD, Xu J. Ribosomal proteins and colorectal cancer. Curr Genomics 2007;8:43-49
11. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007;9:166-180
12. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 1979;86:638-641
13. Ochsner SA, Steffen DL, Hilsenbeck SG, Chen ES, Watkins C, McKenna NJ. GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells. Cancer Res 2009;69:23-26
14. Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for Annotation, Visualization, and Integrated. Discovery Genome Biol 2003;4:P3.
15. Hashimoto K, Goto S, Kawano S, Aoki-Kinoshita KF, Ueda N, Hamajima M, Kawasaki T, Kanehisa M. KEGG as a glycome informatics resource. Glycobiology 2006;16:63R-70R.
16. Kanehisa M. The KEGG database. Novartis Found Symp 2002;247:91-101; discussion 3, 19-28, 244-252
17. Luo JH. Gene expression alterations in human prostate cancer. Drugs Today (Barc) 2002;38:713-719
18. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002;1:203-209 (Pubitemid 41039166)
19. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF, Jr, Hampton GM. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-5978 (Pubitemid 32762523)
20. Yuan J, Horlin A, Hock B, Stutte HJ, Rubsamen-Waigmann H, Strebhardt K. Polo-like kinase, a novel marker for cellular proliferation. Am J Pathol 1997;150:1165-1172 (Pubitemid 27152634)
21. Warbrick E, Coates PJ, Hall PA. Fen1 expression: a novel marker for cell proliferation. J Pathol 1998;186:319-324 (Pubitemid 28494362)
22. Tsimaratou K, Kletsas D, Kastrinakis NG, Tsantoulis PK, Evangelou K, Sideridou M, Liontos M, Poulias I, Venere M, Salmas M, Kittas C, Halazonetis TD, et al. Evaluation of claspin as a proliferation marker in human cancer and normal tissues. J Pathol 2007;211:331-339 (Pubitemid 46172709)
23. Todorov IT, Werness BA, Wang HQ, Buddharaju LN, Todorova PD, Slocum HK, Brooks JS, Huberman JA. HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest 1998;78:73-78
24. Tanaka Y, Kanai F, Tada M, Tateishi R, Sanada M, Nannya Y, Ohta M, Asaoka Y, Seto M, Shiina S, Yoshida H, Kawabe T, et al. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma. J Hepatol 2008;49:746-757
25. Schrader C, Janssen D, Klapper W, Siebmann JU, Meusers P, Brittinger G, Kneba M, Tiemann M, Parwaresch R. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br J Cancer 2005;93:939-945 (Pubitemid 41487021)
26. Olszewski M, Huang W, Chou PM, Duerst R, Kletzel M. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action? Cytotherapy 2005;7:57-61.
27. Li SS, Xue WC, Khoo US, Ngan HY, Chan KY, Tam IY, Chiu PM, Ip PP, Tam KF, Cheung AN. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis. Histopathology 2005;46:307-313
28. Konstantinidou AE, Korkolopoulou P, Kavantzas N, Mahera H, Thymara I, Kotsiakis X, Perdiki M, Patsouris E, Davaris P. Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas. Histol Histopathol 2003;18:67-74. (Pubitemid 36040449)
29. Jalava P, Kuopio T, Juntti-Patinen L, Kotkansalo T, Kronqvist P, Collan Y. Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index. Histopathology 2006;48:674-682
30. Heck MM, Earnshaw WC. Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 1986;103:2569-2581
31. Diop S, Letestu R, Orsolani D, Leboeuf Y, Le Tutour P, Thiam D, Diakhate L, Valensi F. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]. Dakar Med 2005;50:65-68
32. Dietrich DR. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 1993;23:77-109. (Pubitemid 23094395)
33. Karssen AM, Her S, Li JZ, Patel PD, Meng F, Bunney WE Jr, Jones EG, Watson SJ, Akil H, Myers RM, Schatzberg AF, Lyons DM. Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry 2007;12:1089-1102 (Pubitemid 350191369)
34. Vina J, Borras C, Gomez-Cabrera MC, Orr WC. Part of the series: from dietary antioxidants to regulators in cellular signalling and gene expression. Role of reactive oxygen species and (phyto)oestrogens in the modulation of adaptive response to stress. Free Radic Res 2006;40:111-119
35. Sherman M, Multhoff G. Heat shock proteins in cancer. Ann NY Acad Sci 2007;1113:192-201.
36. Li Z, Srivastava P. Heat-shock proteins. Curr Protoc Immunol 2004; Appendix 1:Appendix 1T.
37. Calderwood SK, Ciocca DR. Heat shock proteins: stress proteins with Janus-like properties in cancer. Int J Hyperthermia 2008;24:31-39 (Pubitemid 351167617)
38. Murphy C, McGurk M, Pettigrew J, Santinelli A, Mazzucchelli R, Johnston PG, Montironi R, Waugh DJ. Nonapical and cytoplasmic expression of interleukin-8. CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res 2005;11:4117-4127
39. Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Clin Cancer Res 2007;13:5692-5702 (Pubitemid 47583893)
40. Thomas G. An encore for ribosome biogenesis in the control of cell proliferation. Nat Cell Biol 2002;2:E71-E72.
41. Montanaro L, Mazzini G, Barbieri S, Vici M, Nardi-Pantoli A, Govoni M, Donati G, Trere D, Derenzini M. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines. Cell Prolif 2007;40:532-549 (Pubitemid 47063287)
42. Ayrault O, Andrique L, Larsen CJ, Seite P. [The negative regulation of ribosome biogenesis: a new Arf-dependent pathway controlling cell proliferation?]. Med Sci (Paris) 2006;22:519-524
43. Duncan R, Hershey JW. Heat shock-induced translational alterations in HeLa cells. Initiation factor modifications and the inhibition of translation. J Biol Chem 1984;259:11882-11889 (Pubitemid 14022114)
44. Brostrom CO, Brostrom MA. Regulation of translational initiation during cellular responses to stress. Prog Nucleic Acid Res Mol Biol 1998;58:79-125.
45. Connolly E, Braunstein S, Formenti S, Schneider RJ. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol 2006;26:3955-3965 (Pubitemid 43726410)
46. Dustin ML. Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapses. Curr Opin Cell Biol 2007;19:529-533 (Pubitemid 350019556)
47. Le Clainche C, Carlier MF. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008;88:489-513.
48. Margadant C, van Opstal A, Boonstra J. Focal adhesion signaling and actin stress fibers are dispensable for progression through the ongoing cell cycle. J Cell Sci 2007;120:66-76. (Pubitemid 46206650)
49. Jennbacken K, Gustavsson H, Welen K, Vallbo C, Damber JE. Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity. Prostate 2006;66:1631-1640 (Pubitemid 44646354)
50. Mason MD, Davies G, Jiang WG. Cell adhesion molecules and adhesion abnormalities in prostate cancer. Crit Rev Oncol Hematol 2002;41:11-28. (Pubitemid 34051579)
51. Shah GV, Thomas S, Muralidharan A, Liu Y, Hermonat PL, Williams J, Chaudhary J. Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways. Endocr Relat Cancer 2008;15:953-964
52. Palakurthi SS, Fluckiger R, Aktas H, Changolkar AK, Shahsafaei A, Harneit S, Kilic E, Halperin JA. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res 2000;60:2919-2925 (Pubitemid 30395816)
53. LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH. Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol 2007;27:147-156 (Pubitemid 46013240)